SCHEMBL4187038

SCHEMBL4187038

CC(C)(C)N(C(=O)O)c1ccccc1NC(=O)c1ccc2c(c1)CCC2=NO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
KCNK2 O95069 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
MAPK14 Q16539 4/20 0.36
HTT P42858 1/20 0.36
SRD5A1 P18405 1/20 0.35
SRD5A2 P31213 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GLA P06280 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NR1H4 Q96RI1 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
TOP1 P11387 1/20 0.34
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187034 1.00 RAB9A (0.39) RAB9AMAPTSMN1; SMN2NPC1KCNK2
SCHEMBL4186731 0.81 TOP1 (0.43) RAB9AMAPTSMN1; SMN2NPC1KCNK2
SCHEMBL4186723 0.81 TOP1 (0.43) RAB9AMAPTSMN1; SMN2NPC1KCNK2
SCHEMBL13653103 0.78 TOP1 (0.41) RAB9AMAPTSMN1; SMN2NPC1KCNK2
SCHEMBL28769912 0.76 RAB9A (0.43) RAB9AMAPTSMN1; SMN2NPC1SIRT2
SCHEMBL247987 0.74 CACNA1B (0.57) RAB9AMAPTNPC1HTTALDH1A1
SCHEMBL2107673 0.74 NPC1 (0.42) RAB9AMAPTNPC1ALDH1A1GLA
SCHEMBL20657015 0.73 HDAC1 (0.46) RAB9AMAPTNPC1ALDH1A1GLA
SCHEMBL2107514 0.71 HDAC1 (0.65) RAB9ANPC1ALDH1A1GLAATM
SCHEMBL14932024 0.70 P2RY14 (0.47) HDAC1HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247590-A1 Indane amides BAYER PHARMACEUTICLAS CORPORATION (US) 2009-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247590-A1 Indane amides MKI67, PPIP5K2, CCNA1 RAB9A 4114/4885MAPT 1308/4885SMN1; SMN2 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.